News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Mass General Research Institute – Particular strains of gut bacteria are more prominent in patients with IBD
Jun 27, 2024, 15:48

Mass General Research Institute – Particular strains of gut bacteria are more prominent in patients with IBD

Mass General Research Institute shared on X:

“Researchers from the Smillie Lab at Mass General Research Institute and the Broad Institute identifies particular strains of gut bacteria that are more prominent in patients with inflammatory bowel disease (IBD). “.

Mass General Research Institute

Source: Mass General Research Institute/X

Broad Institute cancer inflammatory bowel disease Mass General Research Institute OncoDaily Oncology Smillie Lab
Blog
Jun 28, 2024, 14:42
Arif Kamal: One of the most beautiful pieces about the need for palliative care
Blog
Jun 28, 2024, 14:34
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
Blog
Jun 28, 2024, 14:30
Manel Esteller: Recruitment of talented young principal Investigators that have blossomed
Blog
Jun 28, 2024, 14:29
Jeff Rathmell: Support funding for cancer research
Societies
Jun 28, 2024, 14:23
Brian G.M. Durie reports the highlights of the IMWG Summit
Blog
Jun 28, 2024, 14:22
Julia Lai-Kwon: Enjoyed a pre MASCC24 visit to Gustave Roussy
Blog
Jun 28, 2024, 14:13
Mark Lewis: Few people make this only child feel more included than Oncology Brothers
Blog
Jun 28, 2024, 14:08
Reflections from NAI2024 by Wafik S. El-Deiry
Blog
Jun 28, 2024, 14:06
Vincent Rajkumar: Cure is a simple word. But there is confusion when it comes to cancer
Societies
Jun 28, 2024, 13:58
EORTC session in gastro-intestinal oncology trials at ESMO GI
Societies
Jun 28, 2024, 13:48
Peter de Gooyer awarded as the best poster presenter in rectal cancer at ESMOGI24
Insight
Jun 28, 2024, 13:48
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24